Acelrx Pharmaceuticals Inc. Stock
A loss of -1.880% shows a downward development for Acelrx Pharmaceuticals Inc.. Our community is currently high on Acelrx Pharmaceuticals Inc. with 3 Buy predictions and 1 Sell predictions. With a target price of €4.00 there is potential for a 219.744% increase which would mean more than doubling the current price of €1.25 for Acelrx Pharmaceuticals Inc.. Our community identified positive and negative aspects for Acelrx Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Acelrx Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Acelrx Pharmaceuticals Inc. in the next few years
Performance of Acelrx Pharmaceuticals Inc. vs. its peers
|Acelrx Pharmaceuticals Inc.||-1.880%||0.631%||34.069%||9.866%||35.437%||-63.778%||-53.004%|
|Concert Pharmaceuticals Inc.||-1.680%||9.317%||12.102%||-57.073%||-64.264%||-78.285%||-67.570%|
|Eiger Biopharmaceuticals Inc||-0.530%||3.950%||-0.074%||-24.607%||-20.592%||-44.910%||-66.650%|
|Heron Therapeutics Inc.||1.530%||14.367%||14.167%||-22.066%||-28.252%||-||-|